Literature DB >> 20399942

Use of the Mirena LNG-IUS and Paragard CuT380A intrauterine devices in nulliparous women.

Richard Lyus, Patricia Lohr, Sarah Prager.   

Abstract

Two intrauterine devices (IUDs) are available in the United States, the levonorgestrel-bearing intrauterine system (Mirena) and the copper-bearing T380A (Paragard). These devices have very low typical-use failure rates but are used by only a minority of women. In particular, there is concern about their use in nulliparous women. We review the available data to address common concerns about using IUDs in this population and show that nulliparous women desiring effective contraception should be considered candidates for IUDs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20399942     DOI: 10.1016/j.contraception.2010.01.010

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  26 in total

1.  Positive Testing for Neisseria gonorrhoeae and Chlamydia trachomatis and the Risk of Pelvic Inflammatory Disease in IUD Users.

Authors:  Natalia E Birgisson; Qiuhong Zhao; Gina M Secura; Tessa Madden; Jeffrey F Peipert
Journal:  J Womens Health (Larchmt)       Date:  2015-04-02       Impact factor: 2.681

2.  Duration of use of a levonorgestrel IUS amongst nulliparous and adolescent women.

Authors:  Tiffany Behringer; Matthew F Reeves; Brianna Rossiter; Beatrice A Chen; Eleanor Bimla Schwarz
Journal:  Contraception       Date:  2011-06-30       Impact factor: 3.375

Review 3.  Challenges in the gynecologic care of premenopausal women with breast cancer.

Authors:  Jamie N Bakkum-Gamez; Shannon K Laughlin; Jani R Jensen; Clement O Akogyeram; Sandhya Pruthi
Journal:  Mayo Clin Proc       Date:  2011-02-09       Impact factor: 7.616

4.  Failed IUD insertions in community practice: an under-recognized problem?

Authors:  Amna I Dermish; David K Turok; Janet C Jacobson; Marie E S Flores; Molly McFadden; Kathy Burke
Journal:  Contraception       Date:  2012-09-11       Impact factor: 3.375

5.  Immediate post-abortion insertion of intrauterine contraceptives (IUC) in a diverse urban population.

Authors:  DeShawn Taylor; Shannon Connolly; Sue Ann Ingles; Carey Watson; Penina Segall-Gutierrez
Journal:  J Immigr Minor Health       Date:  2014-06

6.  Manufacturing and characterization of long-acting levonorgestrel intrauterine systems.

Authors:  Quanying Bao; Bing Gu; Claire F Price; Yuan Zou; Yan Wang; Darby Kozak; Stephanie Choi; Diane J Burgess
Journal:  Int J Pharm       Date:  2018-09-05       Impact factor: 5.875

7.  Counseling Adolescents About the Intrauterine Contraceptive Device: A Comparison of Primary Care Pediatricians With Family Physicians and Obstetrician-Gynecologists in the Bronx, New York.

Authors:  Susan E Rubin; Hillel W Cohen; John S Santelli; M Diane McKee
Journal:  J Prim Care Community Health       Date:  2015-01-27

8.  Identifying counseling needs of nulliparous adolescent intrauterine contraceptive users: a qualitative approach.

Authors:  Margot K Brown; Colette Auerswald; Stephen L Eyre; Julianna Deardorff; Christine Dehlendorf
Journal:  J Adolesc Health       Date:  2012-08-25       Impact factor: 5.012

9.  Celebration meets caution: LARC's boons, potential busts, and the benefits of a reproductive justice approach.

Authors:  Jenny A Higgins
Journal:  Contraception       Date:  2014-02-10       Impact factor: 3.375

Review 10.  Which Hormones and Contraception for Women with APS? Exogenous Hormone Use in Women with APS.

Authors:  Lisa R Sammaritano
Journal:  Curr Rheumatol Rep       Date:  2021-04-30       Impact factor: 4.592

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.